Participate in Research

Browse Clinical Trials
New Study Phase for People with High Blood Pressure
Protocol: STUDY00007844
Full Title
An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects with Uncontrolled Hypertension
Description
The University at Buffalo (UB) Department of Medicine is recruiting adults who have already participated in a past clinical trial for a new phase of the study. Adults with hypertension (high blood pressure) who were previous participants in the Lorundrostat medication study will be eligible to participate. The goal of the study is to see the long-term effects of Lorundrostat in people with high blood pressure that is not well controlled.

Participants be enrolled in the study for about 12 to 13 months and will complete 6 to 8 study visits. Participants will be paid $100 for each study visit.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Adults 18 years or older Have been diagnosed with hypertension (high blood pressure) that is not well controlled Have participated in the previous clinical trial involving Lorundrostat
Age Group: Adults
Principal Investigator: JOSEPH IZZO
ClinicalTrials.gov: Open Study
Contact(s)
KELLEY CAROZZOLO (Bilson)
kjc28@buffalo.edu
+1 716-898-5653

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login